Learn about the FDA’s Office of Trade and Global Partnerships (OTGP) and how its work relates to pharmaceutical products. This discussion will also cover the different types of international agreements and arrangements used by the FDA.

Through the webinar, the audience will learn how OTGP’s work relates to pharmaceutical products and understand the different types of international agreements and arrangements used by FDA. The audience will also learn when and how to contact OTGP.

INTENDED AUDIENCE

• Manufacturers, consultants and professionals:
  • engaged or interested in international trade of pharmaceutical products and drug supply chain issues
  • who have an interest in understanding FDA’s pharmaceutical mutual recognition agreements with foreign regulators
  • involved in the development of pharmaceutical products and combination products that might be impacted by ongoing international negotiations to reduce the use of plastics
• Foreign regulators
• Trade associations

TOPICS

• A general overview of OTGP’s mission, roles, and activities
• Overview of international arrangements and mutual recognition agreements (MRAs) between FDA and foreign drug regulatory authorities and the impact of MRAs on pharmaceutical inspection process
• Why the FDA cares about international trade and OTGP’s role in addressing non-tariff barriers to trade in pharmaceutical products
• Implications of the United Nations (UN) plastics negotiations for pharmaceutical products

Register

1:00 PM – 2:00 PM ET